(Q33939738)

30 July 2017

1 reference

title

Acute hepatic failure: a Western perspective (English)

1 reference

30 July 2017

Ostapowicz G

1

1 reference

PubMed ID

10847432

30 July 2017

Lee WM

series ordinal

2

1 reference

30 July 2017

1 May 2000

1 reference

Journal of Gastroenterology and Hepatology

30 July 2017

1 reference

30 July 2017

15

1 reference

30 July 2017

5

1 reference

30 July 2017

480-488

1 reference

Fulminant hepatic failure: summary of a workshop

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant and subfulminant liver failure: definitions and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Late onset hepatic failure: clinical, serological and histological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Acute liver failure: redefining the syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Etiology and outcome for 295 patients with acute liver failure in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Classification, etiology, and considerations of outcome in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis C Virus Not Found in Fulminant Non-A, Non-B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Infection with GB virus C (GBV-C) in patients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Does GBV-C cause fulminant hepatitis in Japan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis G virus infection in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

GBV-C virus and fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant hepatitis and the new G/GBV-C flavivirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Acetaminophen toxicity in an urban county hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fatal hepatitis after herbal tea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Drug-induced vascular and sinusoidal lesions of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Ecstasy: a common cause of severe acute hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Hepatotoxicity of herbal remedies and mushrooms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Amanita poisoning: treatment and the role of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Orthotopic liver transplantation in a patient with Amanita poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Fulminant liver failure in association with the emetic toxin of Bacillus cereus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

The Budd-Chiari syndrome: a therapeutic Gordian knot?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Brain water and acute liver failure: the emerging role of intracranial pressure monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Complications of intracranial pressure monitoring in fulminant hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

The American experience with transplantation for acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Liver transplantation in Europe for patients with acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Reversal of fulminant hepatic failure using an extracorporeal liver assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

Treatment of fulminant hepatic failure with intravenous prostaglandin E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02074.X

10.1046/J.1440-1746.2000.02074.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10847432